We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+9.31%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$273B
AUM Growth
+$20.9B
Cap. Flow
+$2.91B
Cap. Flow %
1.06%
Top 10 Hldgs %
16.06%
Holding
3,565
New
168
Increased
2,233
Reduced
898
Closed
80

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$892M
2
MRK icon
Merck
MRK
+$858M
3
AMGN icon
Amgen
AMGN
+$857M
4
HD icon
Home Depot
HD
+$837M
5
CSCO icon
Cisco
CSCO
+$781M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$776M
2
UPS icon
United Parcel Service
UPS
+$615M
3
QCOM icon
Qualcomm
QCOM
+$587M
4
BABA icon
Alibaba
BABA
+$555M
5
ETN icon
Eaton
ETN
+$508M

Sector Composition

Rank Sector Weight
1 Technology 19.68%
2 Financials 12.96%
3 Healthcare 11.88%
4 Consumer Discretionary 11.22%
5 Industrials 9.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTGN icon
3376
VistaGen Therapeutics
VTGN
$9.89M
$107K ﹤0.01%
+1,659
New +$111K
TRAW icon
3377
Traws Pharma
TRAW
$6.85M
$107K ﹤0.01%
+284
New +$107K
LNAI
3378
Lunai Bioworks
LNAI
$8.8M
$104K ﹤0.01%
367
-89
-20% -$26.2K
SEAC
3379
DELISTED
Seachange International Inc
SEAC
$101K ﹤0.01%
3,237
DS
3380
DELISTED
Drive Shack Inc.
DS
$101K ﹤0.01%
31,442
+14,227
+83% +$38.6K
SCPS
3381
DELISTED
Scopus BioPharma Inc. Common Stock
SCPS
$100K ﹤0.01%
+11,810
New +$124K
BNED icon
3382
Barnes & Noble Education
BNED
$431M
$97K ﹤0.01%
119
-108
-48% -$74.3K
INFI
3383
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$97K ﹤0.01%
29,948
AQMS icon
3384
Aqua Metals
AQMS
$8.99M
$96K ﹤0.01%
118
+55
+87% +$53.2K
SCPH
3385
DELISTED
scPharmaceuticals
SCPH
$96K ﹤0.01%
14,397
-7,411
-34% -$50.8K
TRVN
3386
DELISTED
Trevena, Inc.
TRVN
$95K ﹤0.01%
84
-34
-29% -$47K
HOFV
3387
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$93K ﹤0.01%
+836
New +$50.6K
LEAF
3388
DELISTED
Leaf Group Ltd.
LEAF
$90K ﹤0.01%
13,902
MMAT
3389
DELISTED
Meta Materials Inc. Common Stock
MMAT
$89K ﹤0.01%
243
+78
+47% +$32.2K
ATXI
3390
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$87K ﹤0.01%
13
MTCR
3391
DELISTED
Metacrine, Inc. Common Stock
MTCR
$86K ﹤0.01%
13,800
ADMS
3392
DELISTED
Adamas Pharmaceuticals
ADMS
$86K ﹤0.01%
17,873
TUSK icon
3393
Mammoth Energy Services
TUSK
$128M
$85K ﹤0.01%
15,843
TIO
3394
DELISTED
Tingo Group, Inc. Common Stock
TIO
$85K ﹤0.01%
+40,861
New +$93K
ELA icon
3395
Envela
ELA
$563M
$84K ﹤0.01%
16,555
MTNB icon
3396
Matinas BioPharma
MTNB
$1.88M
$83K ﹤0.01%
1,568
+866
+123% +$58.1K
EMAN
3397
DELISTED
eMagin Corporation
EMAN
$82K ﹤0.01%
+21,824
New +$73.5K
NMTR
3398
DELISTED
9 Meters Biopharma
NMTR
$80K ﹤0.01%
+3,402
New +$105K
STON
3399
DELISTED
StoneMor Inc.
STON
$80K ﹤0.01%
+42,000
New +$109K
OTLK icon
3400
Outlook Therapeutics
OTLK
$183M
$78K ﹤0.01%
+1,722
New +$65.9K

Similar funds

Charles Schwab's Q1 2021 Portfolio in Review

As of Q1 2021, Charles Schwab held 3,565 positions worth $273B, up 8.3% from $252B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Charles Schwab's Q1 2021 filing shows 168 new, 2,233 increased, 898 reduced and 80 closed positions. Its largest new stake was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M. The largest sale was ExxonMobil, an estimated $776M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q1 2021 buy was State Street Financial Select Sector SPDR ETF: 6,984,918 shares worth $238M.
  • Charles Schwab added most to Broadcom in Q1 2021, an estimated $892M increase.
  • Charles Schwab's biggest Q1 2021 reduction was ExxonMobil, cutting an estimated $776M.
  • Charles Schwab fully exited Invesco QQQ Trust in Q1 2021, selling an estimated $396M.
  • Charles Schwab's ten largest holdings make up 16% of its $273B portfolio in Q1 2021.
  • Charles Schwab opened 168 new positions and closed 80 in Q1 2021.
  • Charles Schwab's portfolio value rose 8.3% quarter-over-quarter to $273B.

Based on Charles Schwab's 13F filing for Q1 2021, filed 17 May 2021.